Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55fa76c9b7175910a5bffb3e26fb5b2a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2015-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87089649461e613779d8b5de820a132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22c243e271b310949e3192875ba6068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901ec256947347cb2b97e5a35570cdac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32a4b4e94d00c6ba6f5ad536583e82b |
publicationDate |
2020-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-I688572-B |
titleOfInvention |
Multivalent molecules comprising dr5-binding domains |
abstract |
A multivalent DR5-Binding Molecules can comprise Binding Domain(s) of anti-DR5 antibodies, and particularly Binding Domain(s) of anti-human DR5 antibodies. The DR5-Binding Molecules include bivalent and tetravalent molecules having two, three or four DR5-Binding Domains each capable of binding human DR5. The multivalent DR5-Binding Molecules can comprise diabodies, and more particularly, diabodies that comprise a covalently bonded complex of two or more polypeptide chains. The multivalent DR5-Binding Molecules can comprise fragments of the anti-DR5 antibodies DR5 mAb 1 and/or DR5 mAb 2, and/or humanized and chimeric versions of such antibodies. |
priorityDate |
2015-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |